Logo-npj

Review

1. Diabetic kidney disease: world wide difference of prevalence and risk factors
Osama Gheith*, Nashwa Farouk, Narayanan Nampoory, Medhat A Halim, Torki Al-Otaibi
J Nephropharmacol. 2016;5(1): 49-56.
Article
PDF
XML
Cited By:
Original

2. Albuminuria in patients with young onset type 2 diabetes
Yassamine Bentata*, Redouane Abouqal
J Nephropharmacol. 2017;6(2): 110-113. doi: 10.15171/npj.2017.14
Article
PDF
XML
Cited By:
0
Original

3. Correlation between adiponectin level with common variant (rs9939609) of fat mass and obesity-associated gene in obese type 2 diabetic women
Fatemeh Shool, Alireza Ostadrahimi, Hajie Lotfi, Maryam Abbasi Majdi, Rasoul Mahmoudi, Mehdi Niknam Moghanloo, Farzaneh Ghafarian Alipour, Sadegh Porfaraj, Nosratollah Zarghami*
J Nephropharmacol. 2017;6(2): 126-133. doi: 10.15171/npj.2017.19
Article
PDF
XML
Cited By:
3
Original

4. Awareness of diabetic nephropathy in patients with type 2 diabetes mellitus: the Indian scenario
Chirag Bansal, Reshma Kaushik*, Rajeev Mohan Kaushik
J Nephropharmacol. 2018;7(2): 90-97. doi: 10.15171/npj.2018.20
Article
PDF
XML
Cited By:
4
Original

5. Multistate Markov model for predicting the natural disease progression of type 2 diabetes based on hemoglobin A1c
Komal Goel*, Gurprit Grover, Ankita Sharma, Sejong Bae
J Nephropharmacol. 2019;8(1): e04. doi: 10.15171/npj.2019.04
Scopus ID: 85079441190    
Article
PDF
XML
Cited By:
5
4
Original

6. Prevalence and characteristics of diabetic kidney disease in type 2 diabetic patients in Abidjan, Côte d’Ivoire
Sindou Sanogo, Serge Didier Konan, Kouamé Hubert Yao*, Emma Kouassi, Séry Patrick Diopoh, Jean Aka, Randolphe Niava, Amos Ankotche
J Nephropharmacol. 2018;7(2): 98-103. doi: 10.15171/npj.2018.21
Article
PDF
XML
Cited By:
0
Original

7. Red cell distribution width as a prognostic marker in diabetes; a pilot cross-sectional study
Saeed Shirali, Sara Bahadoram, Seyed Mohamad Kazem Nourbakhsh, Mohammad Bahadoram*, Ali Asghar Valipour, Fatemeh Javanmardi
J Nephropharmacol. 2019;8(1): e03. doi: 10.15171/npj.2019.03
Scopus ID: 85150169217    
Article
PDF
XML
Cited By:
0
1
Review

8. Association of fetuin-A with kidney disease; a review on current concepts and new data
Marziyeh Akbari ORCID, Hashem Nayeri* ORCID, Hamid Nasri
J Nephropharmacol. 2019;8(2): e14. doi: 10.15171/npj.2019.14
Article
PDF
XML
Cited By:
3
Original

9. The K469E genetic variant in the ICAM1 gene is associated with type 2 diabetes but not with its vascular complications: a meta-analysis
Saikrishna Lakkakula ORCID, Henu Kumar Verma ORCID, Bhaskar V.K.S. Lakkakula* ORCID
J Nephropharmacol. 2020;9(2): e16. doi: 10.34172/npj.2020.16
Scopus ID: 85085890675    
Article
PDF
XML
Cited By:
0
0
Review

10. Metformin induced acute kidney injury; a systematic review
Mahnaz Momenzadeh* ORCID, Bhaskar VKS Lakkakula ORCID
J Nephropharmacol. 2021;10(2): e13. doi: 10.34172/npj.2021.13
Scopus ID: 85111442746    
Article
PDF
XML
Cited By:
1
2
Review

11. Bisphenol A instigates diminished sirtuin-1 mediated vascular complications in type 2 diabetes mellitus
Mohanraj Nehru ORCID, Prasanth Subramanian ORCID, Vinothkumar Ganesan ORCID, Rajiv Janardhanan ORCID, Venkataraman Prabhu* ORCID
J Nephropharmacol. 2024;13(2): e10531. doi: 10.34172/npj.2023.10531
Article
PDF
XML
Cited By:
0
Review

12. Association between type 2 diabetes mellitus and multiple myeloma: Fact or fiction
Ali Rastegar-Kashkouli ORCID, Mohsen Jafari* ORCID, Saina Karami ORCID, Pourya Yousefi ORCID, Amir Mohammad Taravati* ORCID, Ashkan Khavaran ORCID, Dordaneh Rastegar ORCID, Mohammad Reza Jafari ORCID, Seyedeh Yasaman Alemohammad ORCID, Ghader Dargahi Abbasabad, Mohammad Shahbaz ORCID, Mohammad Ebrahimi Kalan ORCID
J Nephropharmacol. 2023;12(2): e10604. doi: 10.34172/npj.2023.10604
Scopus ID: 85161975312    
Article
PDF
XML
Cited By:
0
1